Silencing of ZEB1-AS1 in glioma cells not only resulted in the inhibition of cell cycle, proliferation, migration, invasion, and increased apoptosis, but also in the upregulation of E-cadherin, an epithelial marker, and in the downregulation of mesenchymal marker N-cadherin. Here, ZEB1 is linked to central nervous system cancer.